Acino Holding AG (XSWX:ACIN) Change In Receivables : CHF5.2 Mil (TTM As of Dec. 2013)

View and export this data going back to . Start your Free Trial

What is Acino Holding AG Change In Receivables?

Acino Holding AG's change in receivables for the quarter that ended in Dec. 2013 was CHF5.2 Mil. It means Acino Holding AG's Accounts Receivable declined by CHF5.2 Mil from Dec. 2012 to Dec. 2013 .

Acino Holding AG's change in receivables for the fiscal year that ended in Dec. 2013 was CHF5.2 Mil. It means Acino Holding AG's Accounts Receivable declined by CHF5.2 Mil from Dec. 2012 to Dec. 2013 .

Acino Holding AG's Accounts Receivable for the quarter that ended in Dec. 2013 was CHF65.7 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Acino Holding AG's Days Sales Outstanding for the six months ended in Dec. 2013 was 37.33.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Acino Holding AG's liquidation value for the six months ended in Dec. 2013 was CHF-130.3 Mil.

Acino Holding AG Change In Receivables Historical Data

The historical data trend for Acino Holding AG's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acino Holding AG Change In Receivables Chart

Acino Holding AG Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Change In Receivables

Get a 7-Day Free Trial

-6.39

-26.03

24.08

-4.27

5.20

Acino Holding AG Semi-Annual Data
	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Change In Receivables	Get a 7-Day Free Trial						-6.39	-26.03	24.08	-4.27	5.20

Acino Holding AG Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2013 was CHF5.2 Mil.

Acino Holding AG (XSWX:ACIN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Acino Holding AG's Days Sales Outstanding for the quarter that ended in Dec. 2013 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	65.699	/	321.15	*	91
=	37.33

2. In Ben Graham's calculation of liquidation value, Acino Holding AG's accounts receivable are only considered to be worth 75% of book value:

Acino Holding AG's liquidation value for the quarter that ended in Dec. 2013 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	12.269	-	226.359	+	0.75 * 65.699	+	0.5 * 69.035
=	-130.3

Acino Holding AG Change In Receivables Related Terms

Thank you for viewing the detailed overview of Acino Holding AG's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Acino Holding AG (XSWX:ACIN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acino Holding AG (XSWX:ACIN) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

Website

http://www.acino-pharma.com

Acino Holding AG is a Switzerland-based company engaged in the pharmaceutical industry. The Company develops, manufactures, and markets pharmaceuticals in novel drug delivery forms internationally. It is divided into four segments Business to Consumer (BtC); Business to Business (BtB); Technology marketing (TM); and Production (Prod). The BtC segment comprises all direct marketing activities. Under the company's "Acino Switzerland" brand and, with the promise of Swiss quality, the company sells its products in emerging markets around the globe. This reporting segment includes the business purchased from Mepha/Cephalon in the Middle East, Africa, Latin America and Asia. The BtB segment comprises Acino's business with its internally developed products, for which the company also owns the intellectual property rights. Acino develops and produces high-quality medicines with proven active ingredients and modern drug delivery systems and grants licenses for them to leading pharmaceutical and generic pharmaceutical companies worldwide. The technology marketing segment comprises a broad spectrum of fully integrated contract services, including procurement, contract development, production and packaging for companies in the life sciences industry. On behalf of these customers, Acino develops a comprehensive product pipeline on the basis of its special technological know-how. This includes both new types of medicines as well as projects with innovative drug delivery systems for established active ingredients. The production segment is responsible for the manufacturing of products and the supplying of the other three segments, and generates turnover through the reimbursement of its services. The manufacturing costs of products are credited to the production segment at standard prices along with remuneration in the form of a mark-up for materials and production costs.

Acino Holding AG (XSWX:ACIN) Headlines

No Headlines